XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease
Xortx Therapeutics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Xortx Therapeutics is headquartered in Calgary, Canada.
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease
Xortx Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xortx Therapeutics — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/xortx-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Xortx Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xortx-therapeutics
{{cite web |title=Xortx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xortx-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated